Under 250 mg a day
US adults average well under the 250 mg a day of EPA and DHA that health authorities suggest for heart health.
Peer-reviewed analysisTotal Omega-3 Fatty Acids (from Fish Oil) is the lead active here, studied most for blood flow. 15 human studies on Total Omega-3 Fatty Acids (from Fish Oil) back this formula, each one cited. Who it fits: skews toward women, adults.
Verified by IngredientMDThe panel on the left is the one we evaluated, line by line.
All 3 actives checked against the clinical evidence: dose, form, and what the research actually shows.
Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Backed by human trials".
The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.
Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.
Cross-checked against 246 documented interactions for these actives.
Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.
Under 250 mg a day
US adults average well under the 250 mg a day of EPA and DHA that health authorities suggest for heart health.
Peer-reviewed analysis89% of US adults
aged 19 and over consumed more than the recommended 2,300 milligrams of sodium a day, in a CDC analysis of 2009 to 2012 dietary survey data.
CDC Morbidity and Mortality Weekly Report, 201457.6%
During 2017 to 2018, 57.6% of US adults aged 20 and over reported using a dietary supplement in the past 30 days.
CDC National Center for Health Statistics65.5% of US adults aged 20 to 64
had a blood cholesterol check by a health professional in the past 12 months in 2017, up from 58.0% in 2012, in the National Health Interview Survey.
CDC National Center for Health Statistics, 2019Fewer than 1 in 5 US adults
know their cholesterol or blood sugar numbers, according to a national survey fielded for The Ohio State University Wexner Medical Center in December 2023.
SSRS Opinion Panel Omnibus for The Ohio State University Wexner Medical Center, 20239% of US women
and 5% of US men are getting the recommended daily amount of dietary fibre, based on National Health and Nutrition Examination Survey data collected from 2013 to 2018.
American Society for Nutrition, 202159 to 66 days
was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.
Systematic review and meta-analysis, 202461% to 74%
About 61 to 74 percent of adults refilling a long-term medicine on their own stopped within a year, versus 33 to 44 percent on one set pickup day.
Cohort study, 2015Meta-analysis, 2017
Across 51 trials in about 3,000 people, marine omega-3s lowered resting heart rate by about 2.2 beats per minute, an effect linked to DHA rather than EPA.
European Journal of Clinical NutritionMeta-analysis, 2026
Pooling nine placebo-controlled eccentric-exercise trials in healthy adults, long-chain omega-3 fats reduced delayed onset muscle soreness (Hedges g -0.75) and the muscle-damage marker creatine kinase (-0.40) and improved muscle strength (0.45) and range of motion (0.93) at the point of worst impairment.
NutrientsMeta-analysis, 2021
Across 33 trials, DHA lowered blood triglycerides and raised HDL cholesterol by about 0.07 mmol/L, but also raised LDL cholesterol by about 0.26 mmol/L.
Clinical NutritionMeta-analysis, 2020
Across trials in older adults with mild memory complaints, DHA was linked to better memory test scores, though no difference was detected in those without complaints, which does not mean none exists.
European journal of clinical pharmacologyMeta-analysis, 2026
Pooled trials looked at omega-3s against inflammation markers and recovery measures in sport, with omega-6 relevance only indirect through shared pathways.
FASEB journalMeta-analysis, 2026
Pooling high-dose EPA trials, the authors report that observed cardiovascular outcomes differed by the formulation studied rather than being uniform across preparations.
American Journal of Cardiovascular DrugsMeta-analysis, 2025
Across seven trials in 439 adults with elevated liver fat, fish oil moved triglycerides (standardised mean difference -0.40), the liver enzyme AST (-0.29), insulin resistance measured by HOMA-IR and waist circumference (-0.31) in a favourable direction, while ALT, GGT, body mass index and LDL cholesterol showed no detectable change.
Frontiers in NutritionMeta-analysis, 2022
Across trials, EPA lowered LDL cholesterol about 8.5 mg/L more than DHA, while the two acted much alike on the other markers measured.
Nutrition, Metabolism and Cardiovascular DiseasesMeta-analysis, 2026
Pooled trials found that the EPA to DHA ratio of a supplement shapes which fatty acids rise in the blood, with higher EPA shares linked to larger falls in circulating inflammatory markers, which are blood measures rather than outcomes.
Critical reviews in food science and nutritionSystematic review, 2025
The review found that supplementation raised blood DHA status in people following a long-term protein-restricted diet, with the authors describing the functional outcome evidence as limited.
Frontiers in NutritionMeta-analysis, 2021
In head to head and network comparisons of 20 randomised trials, EPA and DHA moved C-reactive protein, interleukin-6 and TNF-alpha to a similar degree, with no difference detected between the two.
Advances in NutritionMeta-analysis, 2026
A pooled analysis of trials of combined EPA and DHA supplementation reporting change in itch severity scores, a patient-reported measure.
PharmaceuticalsMeta-analysis, 2026
Pooling trials of DHA taken during pregnancy, the review found only small and inconsistent differences in later child neurodevelopmental scores.
Developmental psychobiologyMeta-analysis, 2024
Pooling 15 trials in pregnant women, fish oil capsules showed no detectable difference from placebo in blood sugar or blood lipid measures overall, with a lower HOMA-IR (mean difference -0.60) in the subgroup taking under 200 mg of EPA.
Nutrition ReviewsRandomised trial, 2025
Taking DHA through pregnancy and early lactation raised the DHA content of breast milk compared with control.
Randomised trialMeta-analysis, 2024
Across nine randomised trials, 450 to 800 mg a day of DHA in the second half of pregnancy was linked to infant birth weight about 102 g higher, with no difference detected in gestation length.
Nutrition ResearchMeta-analysis, 2022
Across 71 trials, taking 2 to 3 grams a day of DHA and EPA together lowered the top blood pressure number by about 2.6 points.
Journal of the American Heart AssociationMeta-analysis, 2023
Across 90 trials in 72,598 people, higher daily DHA and EPA intake lowered blood triglycerides and non-HDL cholesterol in a near-linear way, most clear above about 2 g a day.
Journal of the American Heart AssociationPopulation figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.
Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.
In the trial record, EPA in blood plasma plateaus after 4 to 8 weeks of daily fish oil, while EPA in the red blood cell membrane rises with a 28 day half-life and reaches a steady state at about 180 days.
In a randomised single-blind trial, 20 participants took either fish oil supplying 1,296 mg EPA and 864 mg DHA daily or flaxseed oil for eight weeks, with erythrocyte membrane and plasma samples drawn at weeks 0, 4, 8, 10, 12, 14, 16 and 24. On fish oil, erythrocyte membrane EPA rose 300 percent and DHA rose 42 percent by week eight. Levels held until about week 12 and then declined across the post-supplementation sampling, faster in plasma phospholipids than in erythrocyte membranes. Membrane fatty acid content was measured, not a symptom, and this is one trial of 20 people.
In a randomised double-blind crossover trial, healthy men and women aged 19 to 34 took capsules supplying about 4 g DHA per day, with plasma sampled at days 0, 1, 3, 7, 14 and 28. DHA concentrations tripled and so did DHA-derived oxylipins. Increases were detectable as early as day 1, and 11 of 12 individual DHA oxylipins plus total DHA oxylipins reached a plateau by days 5 to 7. The plateau came earlier and was reached by more oxylipins in females than in males. Plasma marker chemistry was measured, not a feeling.
Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.
Three ingredients, from each one's own page.
Membrane incorporation takes weeks. An omega-3 index blood test starts moving by about four weeks and settles across three to four months of daily use.
EPA has to work its way into cell membranes, and an omega 3 index blood test picks up most of the change by weeks eight to twelve of daily use.
Red blood cell omega-3 levels climb over roughly eight to twelve weeks of steady daily intake. That is where the change shows up, on a fatty acid panel rather than as a sensation.
How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.
It is a softgel, so the active is already dissolved in oil and the shell keeps it away from air and light.
Because the effect builds and holds only with continued daily use, a steady recurring supply is the practical way to keep it going.
Put an earned verification on your own product page.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.